Obsidian Therapeutics
OBX · NASDAQ
$13.25+$1.31 (+10.97%)TodayMarket closed ·
Prev close $11.94
OBX analyst rating
BuyConsensus of 4 analysts over the last 12 months. 100% rate it a buy.
- Strong buy0
- Buy4
- Hold0
- Underperform0
- Sell0
12-month price target · 4 analysts
Average $39.78 (+200.2% upside)
- Low
- $32.32
- Now
- $13.25
- High
- $45.15
Upgrades and downgrades
The latest rating actions, newest first
| Firm | Date | Action | Rating |
|---|---|---|---|
| Leerink Partners | Sep 22, 2026 | Initiates | Outperform |
| William Blair | Sep 9, 2026 | Initiates | Outperform |
| LifeSci Capital | Aug 18, 2026 | Initiates | Outperform |
| Piper Sandler | Aug 5, 2026 | Initiates | Overweight |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.